Latest News for: elie

Edit

Elis: Disclosure of trading in own shares occured from February 16 to February 20, 2026

Nasdaq Globe Newswire 24 Feb 2026
Disclosure of trading in own shares occurred. from February 16 to February 20, 2026 ... .
Edit

Air ambulance called to medical matter near Elie

The Courier 24 Feb 2026
Emergency services have been called to the Ruby Bay car park ... .
Edit

MHP lideri Bahçeli'den sert tepki: O bildiriyi imzalayanları toplasan bir insan etmez

Istiklal 24 Feb 2026
Tarafsız ve güvenilir habercilik için tıklayın ....
Edit

Passport delay rules out new recruit Eli Brooks as Ireland name final squad for EuroBasket window

Irish Independent 24 Feb 2026
Ireland have been dealt a blow for ...
Edit

A Tale of Two Titans: Eli Lilly Surges as Novo Nordisk Stumbles in the Weight Loss Price War

The Call 24 Feb 2026
While Eli Lilly and Co ... Most notably, the REDEFINE 4 head-to-head trial results released earlier this month showed that Novo’s next-generation candidate, CagriSema, failed to beat Eli Lilly’s Zepbound in total weight loss ... Eli Lilly and Co.
Edit

Eli Sharabi’s ‘Hostage’ memoir named Jewish book of the year

Sun Sentinel 24 Feb 2026
Eli Sharabi’s memoir “Hostage,” recounting his experience in Hamas captivity after the Oct. 7, 2023 attack, has been named Book of the Year by the National Jewish Book Awards ... I hope it helps ensure that what happened is never forgotten.” ... 7 ... I have to.
Edit

The Giant Mess Behind the Supreme Court’s Tariffs Ruling

The Nation 24 Feb 2026
Elie Mystal ... ....
Edit

Panther swimmer Eli Somers places 8th

Great Bend Tribune 23 Feb 2026
LENEXA — Great Bend Panther Eli Somers placed eighth (1.58.94) in the ...
Edit

Novo Nordisk sinks 10% after weight loss drug fails to match Eli Lilly's in trial

CNBC 23 Feb 2026
Novo Nordisk stock fell as much as 10% Monday after it said its next-generation weight loss drug didn't meet its primary target ... .
Edit

Novo Nordisk's CagriSema Trial Deals a Blow in Obesity Drug Rivalry With Eli Lilly

US News 23 Feb 2026
COPENHAGEN, Feb 23 (Reuters) - Novo Nordisk's next-generation obesity drug CagriSema was ⁠less ⁠effective than Eli Lilly's tirzepatide in a ⁠... .
Edit

Eli Lilly launches new form of obesity drug Zepbound with a month’s worth of doses ...

CNBC 23 Feb 2026
Eli Lilly hopes the device can be more convenient for Zepbound users and lead to more people taking the drug ... .
Edit

Novo Nordisk Stock Falls 15% After 'CargiSema' Fails To Match Eli Lilly's Weight Loss Drug

NDTV 23 Feb 2026
"CargiSema could not achieve its primary endpoint of demonstrating non-inferiority on weight loss." ... .
Edit

Novo Nordisk says weight loss drug fails to match Eli Lilly's in trial

CNBC 23 Feb 2026
CNBC's Annika Kim Constantino delivers the latest news surrounding Novo Nordisk ... .
Edit

Eli Lilly’s Zepbound Gets FDA OK for Multi-Dose Pen

Wall Street Journal 23 Feb 2026
The company said the weight-loss drug will be available at the same self-pay price in either the single-dose vial format or the multi-dose pen that delivers four weekly injections from a single device ... .
Edit

Novo Nordisk shares fall 16% as new obesity drug trails Eli Lilly

The Times/The Sunday Times 23 Feb 2026
CagriSema achieved a 23% weight ...

Article Search

tools
×
×
×
×